DK1138685T3 - Fremgangsmåde til fremstilling af substituerede pyridiner - Google Patents

Fremgangsmåde til fremstilling af substituerede pyridiner

Info

Publication number
DK1138685T3
DK1138685T3 DK01302635T DK01302635T DK1138685T3 DK 1138685 T3 DK1138685 T3 DK 1138685T3 DK 01302635 T DK01302635 T DK 01302635T DK 01302635 T DK01302635 T DK 01302635T DK 1138685 T3 DK1138685 T3 DK 1138685T3
Authority
DK
Denmark
Prior art keywords
substituted pyridines
preparing substituted
preparing
pyridines
substituted
Prior art date
Application number
DK01302635T
Other languages
English (en)
Inventor
Robert Lee Dow
Steven Roy Schneider
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1138685T3 publication Critical patent/DK1138685T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01302635T 2000-03-31 2001-03-21 Fremgangsmåde til fremstilling af substituerede pyridiner DK1138685T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
DK1138685T3 true DK1138685T3 (da) 2004-08-09

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01302635T DK1138685T3 (da) 2000-03-31 2001-03-21 Fremgangsmåde til fremstilling af substituerede pyridiner

Country Status (26)

Country Link
US (4) US6518431B2 (da)
EP (1) EP1138685B1 (da)
JP (1) JP2001316393A (da)
KR (2) KR100435128B1 (da)
CN (1) CN1191235C (da)
AR (1) AR033812A1 (da)
AT (1) ATE267204T1 (da)
AU (1) AU782272B2 (da)
BR (1) BR0101280A (da)
CA (1) CA2342571A1 (da)
CZ (1) CZ20011194A3 (da)
DE (1) DE60103317T2 (da)
DK (1) DK1138685T3 (da)
ES (1) ES2217090T3 (da)
HK (1) HK1038019A1 (da)
HU (1) HUP0101332A3 (da)
ID (1) ID29728A (da)
MX (1) MXPA01003383A (da)
PL (1) PL346805A1 (da)
PT (1) PT1138685E (da)
RU (1) RU2223956C2 (da)
SI (1) SI1138685T1 (da)
TR (1) TR200401359T4 (da)
TW (1) TW555761B (da)
YU (1) YU23301A (da)
ZA (1) ZA200102538B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
EP0906310A4 (en) * 1996-06-07 1999-09-01 Merck & Co Inc OXADIAZOLE-BENZOSULFONAMIDES AS SELECTIVE BETA-3 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETIS AND OBESITY
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
AU728812B2 (en) * 1997-01-28 2001-01-18 Merck & Co., Inc. Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
CA2362070A1 (en) * 1999-02-16 2000-08-24 Masaru Mitsuda Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active .beta.3 agonist by the use of the same

Also Published As

Publication number Publication date
TR200401359T4 (tr) 2004-08-23
CN1191235C (zh) 2005-03-02
HK1038019A1 (en) 2002-03-01
CA2342571A1 (en) 2001-09-30
US20050113578A1 (en) 2005-05-26
US6518431B2 (en) 2003-02-11
MXPA01003383A (es) 2005-08-26
KR100435128B1 (ko) 2004-06-09
AU3334801A (en) 2001-12-13
KR20030072295A (ko) 2003-09-13
AU782272B2 (en) 2005-07-14
US20020077478A1 (en) 2002-06-20
DE60103317T2 (de) 2005-06-16
EP1138685B1 (en) 2004-05-19
ID29728A (id) 2001-10-04
RU2223956C2 (ru) 2004-02-20
US6844441B2 (en) 2005-01-18
ES2217090T3 (es) 2004-11-01
EP1138685A2 (en) 2001-10-04
ATE267204T1 (de) 2004-06-15
DE60103317D1 (de) 2004-06-24
AR033812A1 (es) 2004-01-07
EP1138685A3 (en) 2003-04-02
US20030114670A1 (en) 2003-06-19
CN1320596A (zh) 2001-11-07
KR20010095192A (ko) 2001-11-03
BR0101280A (pt) 2001-11-06
ZA200102538B (en) 2002-09-30
CZ20011194A3 (cs) 2002-02-13
US20040133005A1 (en) 2004-07-08
PL346805A1 (en) 2001-10-08
PT1138685E (pt) 2004-08-31
HUP0101332A3 (en) 2004-07-28
HUP0101332A2 (en) 2002-10-28
TW555761B (en) 2003-10-01
SI1138685T1 (en) 2004-12-31
YU23301A (sh) 2003-04-30
HU0101332D0 (en) 2001-06-28
US6670480B2 (en) 2003-12-30
JP2001316393A (ja) 2001-11-13
KR100481603B1 (ko) 2005-04-08

Similar Documents

Publication Publication Date Title
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1161426T3 (da) Fremgangsmåde til fremstilling af furfural
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1182261T3 (da) Fremgangsmåde til frembringelse af basisk aminosyre
DK1412459T3 (da) Fremgangsmåde til fremstilling af mellemdestillater
DK2258688T3 (da) Pyridinon-derivater til behandling af aterosklerose
DK1317181T3 (da) Fremgangsmåde til fremstilling af en herbicid faststofformulering
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1255719T3 (da) Integreret fremgangsmåde til fremstilling af en alkenylsubstitueret aromatisk forbindelse
DK2135957T3 (da) Fremgangsmåde til fremstilling af glucaner
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1330370T3 (da) Fremgangsmåde til fremstilling af overfladeelementer
DK1373268T3 (da) Fremgangsmåde til fremstilling af anagrelid
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1210318T3 (da) Fremgangsmåde til fremstilling af adrenalin
DK1401816T3 (da) Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1300160T3 (da) Fremgangsmåde til stabilisering af en sammensætning
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1138685T3 (da) Fremgangsmåde til fremstilling af substituerede pyridiner
DK1417207T3 (da) Fremgangsmåde til fremstilling af 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-oner